Exhaled monoxides in asymptomatic atopic subjects

Area of Science:

• Respiratory Medicine
• Immunology
• Biomarkers

Background:

• Atopy is a genetic predisposition that can lead to airway hyperresponsiveness and asthma.
• Airway inflammation may precede clinical asthma symptoms, necessitating early detection methods.
• Inflammatory mediators can induce nitric oxide synthase and heme oxygenase, increasing airway nitric oxide (NO) and carbon monoxide (CO).

Purpose of the Study:

• To assess exhaled NO and CO levels in atopic and nonatopic healthy individuals.
• To determine if airway inflammation is present in asymptomatic atopic subjects.

Main Methods:

• Exhaled NO measured via chemiluminescence.
• Exhaled CO measured electrochemically.
• Measurements performed on asymptomatic atopic and age-matched nonatopic subjects.

Main Results:

• Exhaled NO levels were significantly higher in atopic subjects (18.3+/-3.0 p.p.b.) compared to nonatopic individuals (6.3+/-0.3 p.p.b.).
• Exhaled CO levels were also significantly elevated in atopic subjects (4.7+/-0.3 p.p.m.) versus nonatopic subjects (2.8+/-0.2 p.p.m.).
• Statistical significance was observed for both NO (P<0.0001) and CO (P=0.0005) differences.

Conclusions:

• Increased exhaled monoxide levels may serve as an early, noninvasive marker.
• This marker can potentially identify airway inflammation in asymptomatic atopic individuals.
• Further research could validate these findings for clinical application in asthma prediction.